SCHEMBL463154

SCHEMBL463154

CCNC(=O)c1ccc(-c2cnc3c(NCCOC)cc(Oc4cc(F)ccc4C)nn23)cc1C

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TTK P33981 19/20 0.56
FYN P06241 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17416390 0.92 TTK (0.57) TTKFYNMKNK1
SCHEMBL10279126 0.92 TTK (0.54) TTKMKNK1
SCHEMBL470069 0.91 TTK (0.66) TTK
SCHEMBL17590109 0.91 TTK (0.56) TTKFYNMKNK1
SCHEMBL15555779 0.90 TTK (0.51) TTK
SCHEMBL15556862 0.88 TTK (0.60) TTK
SCHEMBL10279277 0.88 TTK (0.55) TTK
SCHEMBL15555447 0.87 TTK (0.58) TTK
SCHEMBL15556189 0.86 TTK (0.67) TTKFYN
SCHEMBL469987 0.85 TTK (0.69) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP claimed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO claimed
US-9255100-B2 Substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-02-09 US disclosed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed